** Brokerage UBS downgrades life and health reinsurer Reinsurance Group of America RGA.N to "neutral" from "buy"; cuts PT to $216 from $250
** Cites execution risk on annual capital deployment target as well as on the Equitable Holdings EQH.N deal
** Says the recent overhang on shares to persist over the near term as management executes its newer, more aggressive growth strategy
** "Reliance on 3rd party capital to meet EPS growth can be seen as "stretching" for a global reinsurance franchise historically known for its conservativism," says brokerage
** Nine of 12 brokerages rate stock "buy" or higher, and 3 "hold"; median PT is $250 — LSEG data
** Including session moves, RGA stock down ~6.7% YTD, compared to a 4.2% decline in the S&P 500 .SPX
(Reporting by Ateev Bhandari in Bengaluru)
((Ateev.Bhandari@thomsonreuters.com))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。